Bicycle Therapeutics logo

Bicycle Therapeutics

BCYC | NASDAQ
Chart Builder DCF Calculator
$3.18
-$0.19 (-5.64%)
At close: Nov 16, 2026, 4:00 PM ET
$3.22
+$0.04 (+1.26%)
After-hours: Nov 16, 2026, 7:30 PM ET
-5.64%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
42.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #450/1021 (Top 44%)

Key Statistics

Market Data

Market Cap $222.58M
1D Range
3.07 3.36
52W Range
3.07 7.52

Valuation (TTM)

PE -1.57
PB 0.44
EV/EBITDA 1.74

Valuation (NTM)

Forward PE N/A
Forward PEG 0.04
Price Target $10.00
Loading financial charts...

Profile

Bicycle Therapeutics plc, founded in 2009 and based in Cambridge, UK, is a clinical-stage biopharmaceutical company. Its core mission is to create innovative therapeutic classes for diseases currently...

Sector Healthcare
Industry Biotechnology
Employees 288
IPO Date May 23, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Oct 29, 2026
EPS
-$0.15
Beat +50.00%
REV
$34.06M
Beat +178.74%
Next Earnings
Mar 16, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$10.00
Upside
+214.47%
Buy (3)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.